Skip to content

   
Welcome to AstraZeneca's international website. As one of the world's leading pharmaceutical companies, our business is focused on turning good ideas into innovative, effective medicines that make a real difference in important areas of healthcare.
Latest news
> 14 August 2008 : AstraZeneca and Abbott Expand Relationship to Include Co-Promotion of CRESTOR®
> 31 July 2008 : Second Quarter and Half Year Results 2008
> 23 July 2008 : AstraZeneca and Bristol-Myers Squibb Submit New Drug Application in the United States and Marketing Authorisation Application in Europe for ONGLYZA™ (Saxagliptin) for the Treatment of Type 2 Diabetes
Features
Read more about our new Code of Conduct, which reflects our continued commitment to doing business the right way.
AstraZeneca websites
Search
Quick links
Information for
US visitors
Share price
> London
> New York
> Stockholm
AstraZeneca news feed
 Terms of use  Privacy policy    © AstraZeneca PLC 2003 - 2008